Prognostic Significance of Controlled Attenuation Parameter in Patients With Compensated Advanced Chronic Liver Disease

Obesity and steatosis have been associated with liver disease progression in patients with compensated advanced chronic liver disease (cACLD) (liver stiffness measurement [LSM] ≥ 10 kPa). The controlled attenuation parameter (CAP) estimates steatosis during LSM by transient elastography. We aimed to...

Descripción completa

Detalles Bibliográficos
Autores principales: Margini, Cristina, Murgia, Giuseppe, Stirnimann, Guido, De Gottardi, Andrea, Semmo, Nasser, Casu, Stefania, Bosch, Jaime, Dufour, Jean‐François, Berzigotti, Annalisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078211/
https://www.ncbi.nlm.nih.gov/pubmed/30094404
http://dx.doi.org/10.1002/hep4.1201

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078211/
https://www.ncbi.nlm.nih.gov/pubmed/30094404
http://dx.doi.org/10.1002/hep4.1201

Ejemplares similares